NCT07325929 Online Radical Acceptance Intervention for Social Anxiety Disorder
| NCT ID | NCT07325929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Haifa |
| Condition | Social Anxiety Disorder (SAD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-12-16 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-12-16 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a self-guided online Radical Acceptance program helps reduce symptoms of Social Anxiety Disorder. The study will also compare this program to an online relaxation skills program. The main questions are: * Does the Radical Acceptance program lower symptoms of Social Anxiety Disorder? * Is the Radical Acceptance program more helpful than relaxation skills? Adults with Social Anxiety Disorder will be randomly assigned to one of two online programs. They will complete a baseline learning session and six short home practice sessions over two weeks. Participants will answer surveys about their symptoms and complete brief computer tasks. Researchers will measure changes in social anxiety at several points during the study and again a few weeks and a few months later.
Eligibility Criteria
Inclusion Criteria: * Aged 18-45 * Score \> 9 on Mini-SPIN * Positive responses in brief phone screening * Eligibility confirmed in Zoom interview using ADIS * Native Hebrew speakers * Having regular access to a computer. Exclusion Criteria: * Changes in psychiatric medication in the past 3 months * Current or past diagnosis of bipolar disorder * Current or past diagnosis of schizophrenia * Current or past diagnosis of PTSD * Current or past diagnosis of substance use disorder * History of traumatic brain injury (TBI) * Previous experience with Dialectical Behavior Therapy (DBT) * Currently receiving psychotherapy specifically targeting social anxiety
Contact & Investigator
Noam Weinbach, PhD
PRINCIPAL INVESTIGATOR
School of Psychological Sciences, University of Haifa
Frequently Asked Questions
Who can join the NCT07325929 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Social Anxiety Disorder (SAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325929 currently recruiting?
Yes, NCT07325929 is actively recruiting participants. Contact the research team at nweinbach@psy.haifa.ac.il for enrollment information.
Where is the NCT07325929 trial being conducted?
This trial is being conducted at Haifa, Israel.
Who is sponsoring the NCT07325929 clinical trial?
NCT07325929 is sponsored by University of Haifa. The principal investigator is Noam Weinbach, PhD at School of Psychological Sciences, University of Haifa. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.